𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Elective ipsilateral neck irradiation of patients with locally advanced maxillary sinus carcinoma

✍ Scribed by Branislav Jeremic; Yuta Shibamoto; Biljana Milicic; Nebojsa Nikolic; Aleksandar Dagovic; Jasna Aleksandrovic; Zeljko Vaskovic; Ljiljana Tadic

Publisher
John Wiley and Sons
Year
2000
Tongue
English
Weight
81 KB
Volume
88
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

✦ Synopsis

Background:

The current study was conducted to investigate retrospectively whether elective ipsilateral neck irradiation (eini) is effective in controlling subclinical neck disease in patients with locally advanced (t3 and t4) nonmetastatic (n0, m0) squamous cell carcinoma (scc) of the maxilla.

Methods:

Between 1987 and 1993 a total of 44 patients were treated with eini. the primary tumor bed was treated with 60 grays (gy) in patients undergoing radical maxillectomy or with 66 gy in patients undergoing partial maxillectomy. the ipsilateral upper and lower neck (down to the clavicle) was treated with either opposing anteroposterior-posteroanterior fields or appositional electron fields. the dose of elective neck radiotherapy was 50 gy in 25 daily fractions.

Results:

The 5-year and 10-year survival rates (with standard error [se]) were 66% (se 7%) and 60% (se 8%), respectively, whereas the 5-year and 10-year recurrence free survival rates both were 64% (se 7%). the 10-year local recurrence free survival rate was 69% (se 7%), whereas the 10-year regional recurrence free survival rate was 94% (se 4%). of the 2 patients who developed a recurrence in the neck, 1 was salvaged successfully by surgery, producing an ultimate 10-year regional recurrence free survival rate of 97%. the 10-year distant metastasis free survival rate was 91% (se 4%).

Conclusions:

The findings of the current study appear to suggest the potential efficacy of eini in patients with locally advanced, nonmetastatic scc of the maxilla and that the high rate of control of cervical lymph nodes may lead to better overall survival than that reported in the majority of the recent series.

πŸ“œ SIMILAR VOLUMES

Hyperfractionated radiation therapy and
Hyperfractionated radiation therapy and 5-fluorouracil, cisplatin, and mitomycin-C (Β± granulocyte-colony stimulating factor) in the treatment of patients with locally advanced head and neck carcinoma
✍ AndrΓ© A. Abitbol; Kasi S. Sridhar; Alan A. Lewin; James G. Schwade; William Raub πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 166 KB πŸ‘ 2 views

initial entry of 34 patients. Cancer Center, University of Miami School of RESULTS. At a median follow-up of 41 months (range, 12-80 months), 44 patients Medicine, Miami, Florida. were alive with a projected median overall survival of 54 months. Grade 3/4 muco-2 Regional Cancer Center, Baptist Hosp

A phase II trial of cisplatin, methotrex
A phase II trial of cisplatin, methotrexate, levofolinic acid, and 5-fluorouracil in the treatment of patients with locally advanced, metastatic squamous cell carcinoma of the head and neck
✍ Francesco Caponigro; Pasquale Comella; Paolo Marcolin; Francesco Russo Spena; Ma πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 89 KB πŸ‘ 2 views

## Background: Induction chemotherapy in locoregionally advanced squamous cell carcinoma of the head and neck (scchn) might improve survival with respect to radiation therapy alone. furthermore, chemotherapy represents the only therapeutic option in metastatic head and neck carcinoma. ## Methods: